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Acute upper gastrointestinal bleeding (UGIB) is a common
cause of emergency hospital admission and is associated with
substantial health expenditure.1 The condition is also not
uncommon among already-hospitalised patients.
Despite improved technology in the management of UGIB,
mortality has remained high.  This has been attributed to the
increase in the population of elderly people who tend to have
other underlying diseases leading to the high mortality rate.
According to international literature, mortality varies from 4%
to 10%.2,3 The bulk of severe morbidity and mortality occurs in
patients with recurrent bleeding or significant co-morbid
illness.4
The use of non-steroidal anti-inflammatory drugs (NSAIDs),
common in the elderly, more than doubles mortality associated
with peptic ulcer complications.5
Endoscopy has traditionally been used to risk-stratify
patients with UGIB.6 This approach may be inappropriate in
large areas of South Africa where endoscopy is not readily
available. Ideally, to avoid waste of limited resources and time,
it would be helpful to identify patients in whom endoscopy
could be delayed without deleterious outcome, reserving
emergency endoscopy for patients at highest risk for both re-
bleeding, morbidity and mortality.  In this class of patients
endoscopy is used not only for diagnosis but also for
endoscopic treatment to control massive ulcer bleeding.
From the time that research and debate on factors
influencing the outcome of acute upper gastro-intestinal
haemorrhage began, age, co-morbidity, shock, admission
haemoglobin values, presentation (either with haematemesis,
melaena or both), ulcer type, ulcer size, stigmata of recent
haemorrhage (visible vessel in an ulcer bed, ooze, fresh clot)
and transfusion requirement have all been described as
significant risk factors for further haemorrhage and death.7
However, there is no universal agreement on a set of risk
factors as researchers have emphasised different factors
according to their experience and have used different
endpoints.2
Until recently, no study had attempted to devise a simple
and therefore clinically useful risk scoring system that would
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Objective.  Endoscopy has traditionally been used to risk-
stratify patients with upper gastrointestinal bleeding (UGIB).
This is problematic in resource-poor environments. The study
aimed to identify patients who would not require urgent
endoscopy by identifying clinical variables before endoscopy
that predict uneventful recovery.
Design.  Prospective, descriptive cross-sectional study.
Setting. Groote Schuur Hospital, Cape Town.
Subjects. Two hundred consecutive patients aged over 12
years, presenting with haematemesis and/or melaena. 
Outcome  measures. Good outcome, i.e. no blood transfusion,
endotherapy or surgery, and alive at 1 month following
presentation.  
Results.  Eighty patients (40%) had a good outcome.
Haemoglobin  > 10 g/dl  (odds ratio (OR) 25.5, 95%
confidence interval (CI): 8.9 - 74.8; p < 0.001), absence of
melaena (OR 4.8, 95% CI: 1.79 - 12.94, p = 0.002) and absence
of syncope (OR 4.0, 95% CI: 1.67 - 9.48; p = 0.002) were
independent predictors of good outcome. The three variables
combined as a positive test had the best association with
good outcome when compared with a single variable or a
combination of two variables. The three-variable model had
sensitivity for good outcome of 34%, specificity of 98%, and
likelihood ratio for a positive test of 13.5 and for a negative
test of 0.68.  Thirty patients (15%) had the combination for the
prediction rule, i.e. haemoglobin > 10 g/dl, no melaena and
no syncope; 3 (10%) had a poor outcome (required
endotherapy). 
Conclusion.  The prediction rule accurately excluded poor
outcome, a priority in the clinical context, but did not predict
good outcome. Clinical implications are a 15% reduction in
unnecessary urgent endoscopies, with less than 5% of
patients with poor outcome not undergoing urgent
endoscopy.  These findings may have particular clinical
relevance in under-resourced health care environments. 
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be readily available to the clinician for categorising patients by
risk. Of the studies that have investigated predictors of
outcome, a large number have looked at predictors of adverse
outcome (re-bleed, death and surgery). Very few studies have
looked at predictors of good outcome. Even then, most of these
studies have included endoscopic findings in their decision
criteria.6,8
Does a predictor of good outcome equal the absence of a
predictor of poor outcome? It is not possible to implement the
opposite of predictors of adverse outcome as being predictors
of good outcome, as endpoints in the studies would be
different.  For example, factors that predict mortality, such as
age and co-morbidity, are not necessarily predictive of
persistent or recurrent bleeding.9
Of principal concern is the safety of patients who would be
discharged from primary and secondary health care facilities
for deferred endoscopy examination. There is a need to isolate
those predictors of good outcome able to classify patients who
could be safely discharged on medical therapy without prior
endoscopy and recover without any adverse event. The
decision rule would be used only to delay (urgent) endoscopy;
a diagnostic endoscopy would still be done. Diagnostic
endoscopy without a therapeutic procedure does not alter
mortality, although in most cases it provides information on
the source of bleeding.
Given the scarcity of information on the non-endoscopic
triage of patients, a prospective study of patients with acute
upper gastro-intestinal haemorrhage was undertaken to
identify patients at low risk for an adverse outcome following
acute UGIB at Groote Schuur Hospital in Cape Town.
Study population and methods
Consecutive patients over the age of 12 years presenting to the
Emergency Unit with haematemesis and/or melaena between
October 1997 and August 1998, were prospectively studied.
Patients were excluded if: (i) their initial presentation was to
another hospital that instituted resuscitative measures; ( ii) they
were known to have oesophageal varices or upper gastro-
intestinal malignancy; (iii) they presented with anaemia
without a clear history of UGIB; or (iv) if they developed UGIB
during the course of hospitalisation for another problem.
Data were collected using a structured clerking sheet
designed for the study, which included demographic
characteristics; mode of presentation, i.e. haematemesis and/or
melaena; history of pre-syncope (near fainting or extreme
dizziness) or syncope (transient loss of consciousness with loss
of postural tone); medication use, particularly non-steroidal
anti-inflammatory drugs (NSAIDs), salicylates or warfarin;
alcohol use; history of previous peptic ulcer disease;
haemoglobin concentration; pulse; systolic blood pressure
(SBP); postural hypotension; and co-morbidity. Each patient
underwent endoscopic examination.
The criteria for a good outcome were: (i) non-performance of
an endoscopic procedure (endotherapy) to control bleeding,  a
therapeutic surgical procedure, or a blood or blood product
transfusion; and (ii) alive within 1 month of initial presentation.
Patients were followed up at 1 month after hospital discharge.
Blood transfusion was taken to be a poor-outcome event
because of the laboratory, medical and nursing expertise
required in its administration, as well as being an indicator of
significant bleeding. Endotherapy and surgery were regarded
as poor-outcome criteria because these services require trained
specialists who are only available at some secondary level
hospitals and at no primary level hospitals. Hence all patients
with UGIB requiring such interventions need to be referred to
centres where these facilities are available. Death is the end-
point that we all strive to reduce.
Data analysis
Data were entered into a standard spreadsheet (Excel), and
univariate, bivariate and multivariate descriptive statistics
were derived using Statistica Version 5.1 (1998) software.
Bivariate analysis for individual predictive factors of good
outcome was performed using the chi-square test. Continuous
variables were compared using the unpaired t-test. To increase
clinical relevance the continuous variables were converted into
categorical variables using internationally acceptable ranges
defining severity of an UGIB. Statistical significance was
accepted at p < 0.05 (two-tailed).
Clinical predictors that showed significant association with
good outcome on bivariate analysis were entered into a
multiple logistical regression model. A final model was selected
using stepwise multiple logistical regression analyses.
Sensitivity, specificity, positive predictive value, negative
predictive value, likelihood ratio (LR) for a positive test and LR
for a negative test were calculated individually and in
combination for variables that were found to be independently
associated with outcome.
LRs are measures of the accuracy with which a diagnostic
test identifies its target disorder in an individual patient. They
are regarded as the most useful indicators of test accuracy in a
clinical context involving individual patients. The higher the
ratio is above 1, the greater the change in probability in favour
of the condition of interest; the lower the ratio below 1, the
greater the change in probability against the condition of
interest.10
The investigators pre-specified a predictive tool with a
specificity of not less than 95% as an acceptable benchmark, i.e.
no more than 5% of patients with poor outcome should miss
urgent endoscopy.
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Ethics approval
The study was approved by the Ethics and Research
Committee of the Faculty of Health Sciences, University of
Cape Town.
Results
Over the 10-month study period, a total of 306 patients were
admitted to the Emergency Unit with a diagnosis of haemate-
mesis and/or melaena. A total of 200 of these patients (65.4%)
met the inclusion criteria and were included in the final
analysis.
The median age of the 200 patients was 57.5 years (range 19 -
93 years).  One  hundred and twenty-two patients (61%) were
males and 78 (39%) were females.
One hundred and two of the patients (51%) had blood
transfusions with 11 (5.5%) requiring more than five units of
blood. Thirty-five (17.5%) had endoscopic therapy, and 8 (4%)
underwent surgery. There were 13 deaths (6.5%), of which 8
deaths were related to gastrointestinal haemorrhage, while 5
were related to other underlying co-morbidity. Bleeding-related
mortality was 4% and mortality due to underlying co-
morbidity was 2.5%. Of the 200 patients, 80 (40%) had a good
outcome (no transfusion, endotherapy or surgery, and alive at 1
month after presentation).
On bivariate analysis, age, pulse, SBP, haemoglobin, history
of pre-syncope or syncope (syncope), anticoagulant use,
presentation with either melaena or haematemesis, and co-
morbidity were significant predictors of outcome. Variables not
associated with outcome were use of NSAIDs, salicylates,
alcohol and history of previous peptic ulcer disease (Table I).
Although not predictive of outcome, current intake of
salicylates or NSAIDs was significantly associated with the
diagnosis of peptic ulcer disease on endoscopy (relative risk
(RR) 1.79, 95% confidence interval (CI): 1.33 - 2.40, p < 0.001).
On multiple logistical regression analysis, absence of
melaena, absence of history of pre-syncope or syncope, and
haemoglobin value greater that 10 g/dl were independent
predictors of good outcome (Table II). These three variables
were included in the final model selected (Table III).
The selected model had sensitivity for good outcome of 34%
(95% CI: 27 - 40%), specificity of 98% (95 - 100%), positive
predictive value of 90% (86 - 94%) and negative predictive
value of 69% (62 - 75%). The likelihood ratio for a positive
(LR+) test was 13.5 (5.3 - 54.0) and the likelihood ratio for a
negative (LR–) test was 0.68 (0.57 - 0.79). In this study, using
this model, 72% of patients were correctly classified.
A model taking any two of the three variables as a positive
test had lower specificity of 83% (78 - 88%), and lower LR+ 
of 4.4.
Discussion
This prospective study was undertaken to define predictors of
good outcome (i.e. no transfusion, endotherapy or surgery, and
Table I. Predictors of good outcome (no transfusion, endoscopic
therapy or surgery, and alive at 1 month) (bivariate logistical
regression analysis)
RR 95% CI  for RR P-value
Age < 60 years 1.58 1.10 - 2.28 0.01
Pulse < 100 beats/min 1.76 1.18 - 2.60 0.003
SBP>100 mmHg 4.58 1.20 - 17.30 0.002
Hb > 10 g/dl 10.50 4.80 - 23.0 < 0.001
Syncope 0.43 0.29 - 0.62 < 0.0001
Warfarin 1.67 1.28 - 2.19 0.006
Co-morbidity 0.67 0.48 - 0.94 0.02
Haematemesis 1.72 1.14 - 2.59 0.005
Melaena 0.58 0.39 - 0.88 0.005
NSAIDs/salicylates 0.82 0.58 - 1.17 0.26
Alcohol 1.27 0.86 - 1.88 0.25
Previous PUD 0.90 0.62 - 1.32 0.59
RR = relative risk; CI = confidence interval; SBP= systolic blood pressure; Hb =
haemoglobin; NSAIDs = non-steroidal anti-inflammatories; PUD = peptic ulcer
disease.
Table II. Predictors of good outcome (no transfusion, endoscopic
therapy or surgery, and alive at 1 month) (multiple logistical
regression analysis)
Odds ratio (OR) 95% CI  for OR P-value
No melaena 5.21 1.36 - 19.93 0.01
No haematemesis 0.96 0.29 - 3.10 0.95
No syncope 3.80 1.44 - 10.09 0.006
No warfarin 0.76 0.11 - 5.25 0.78
Hb >10 g/dl 22.97 6.85 - 76.98 < 0.0001
Pulse < 100 beats/min 2.37 0.78 - 7.10 0.12
SBP>100 mmHg 2.48 0.34 - 18.01 0.36
Age < 60 years 1.09 0.36 - 3.35 0.87
No co-morbidity 1.03 0.34 - 3.14 0.95
CI = confidence interval; Hb = haemoglobin; SBP= systolic blood pressure.
Table III. Final model — predictors of good outcome
Odds ratio 95% CI  for OR P-value
No melaena 4.8 1.79 - 12.94 0.002
Hb >10g/dl 25.8 8.9 - 74.8 < 0.0001
No syncope 3.98 1.67 - 9.48 0.002
CI = confidence interval; Hb = haemoglobin.
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alive at 1 month) in patients presenting with acute UGIB, with
a view to identifying criteria for the selection of patients who
would recover uneventfully without need for urgent
endoscopy.
Eighty of the patients (40%) had a good outcome. One
hundred and two (51%) had blood transfusion, 35 (17.5%) had
endotherapy and 8 (4%) underwent surgery. The total mortality
of 6.5% was within the range of most other studies. The main
finding of the study was that absence of melaena, the absence
of syncope and haemoglobin greater than 10 g/dl were
predictors of good outcome, as pre-defined.
Some of the findings warrant comment:
1. The role of co-morbidity as a predictor of outcome has
been confirmed in other studies.3,11 In the present study,
although co-morbidity was a predictor of poor outcome (Table
I), this association was lost on multivariate analysis.
2. It is surprising that age, like co-morbidity, was a predictor
of outcome on bivariate but not on multivariate analysis.
Advanced age has been associated with adverse outcome in
many other studies. The findings of this study were similar to
findings of some previous studies that identified low-risk
patients with UGIB. 7 The lack of association after adjustment in
the multivariate model indicates that in this sample,
haemoglobin greater than 10 g/dl and the absence of melaena
or syncope were associated with a younger age and better
predicted outcome.
3. Current intake of salicylates/NSAIDs was associated with
an increased risk of peptic ulcer disease at endoscopy (RR 1.79,
95% CI: 1.33 - 2.40, p < 0.001) but was not significantly
associated with outcome (Table I). The use of these drugs has
been associated with increased risk of peptic ulcer occurrence,
ulcer complication (haemorrhage or perforation) and death. 12
Case control studies have found the increased risk of UGIB
in patients taking NSAIDs to have a linear dose-response
relationship.12 The correlation between risk of peptic ulcer
disease and dosage was not explored in this study. The
inclusion of patients taking minimal doses of NSAIDs could
have impacted on its association with outcome.
4. On bivariate analysis, presentation with haematemesis
alone was associated with good outcome, while presentation
with melaena alone was associated with poor outcome (Table
I). This is unlike findings in most studies where haematemesis
is associated with an adverse outcome.3, 13 The difficulty in
comparing these studies with our study is that these studies
included patients with varices who tend to present with
haematemesis and are at high risk of a poor outcome. The
other factor is that endpoints differ in different studies. The
perceived need for blood transfusion as part of the outcome
measures was included because of the perceived lack of
expertise required for its administration at primary health care
centres. We hypothesise that patients presenting with melaena
alone may present late to hospital, as the bleeding is less brisk
and less alarming. Therefore, they may present with much
lower haemoglobin levels and require blood transfusion.
5. Syncope is correlated with rapidity of blood loss. This
variable has been incorporated as a predictor of outcome in
very few studies. Those studies that included syncope as a
predictor variable found it not to be a predictor of mortality.3, 4
Nevertheless, we cannot compare our findings with these
studies, as their endpoint was mortality. In the American
Society for Gastrointestinal Endoscopy survey,3 syncope was
associated with blood transfusion of more than five units.
6. Haemoglobin, pulse and SBPare all measures of severity
of the bleed. These variables have been used in many studies
as predictors of outcome. On bivariate analysis, using inter-
nationally accepted cut-off levels for low risk of adverse
outcome,14 haemoglobin greater than 10 g/dl, pulse rate less
than 100 beats/minute and SBPgreater than 100 mmHg were
significantly associated with a good outcome. However, on
multivariate analysis, pulse rate and blood pressure lost
statistical significance. This is probably due to the association
between pulse rate, blood pressure levels and haemoglobin
value that was adjusted for in the multivariate model.
On multiple logistical regression analysis, in the final model,
absence of melaena, absence of syncope and haemoglobin
greater than 10 g/dl were the predictors of good outcome
(Table III). A combination of all three variables significantly
improved the association. The improved specificity, predictive
values and LRs of the combined variables demonstrate this.
Increasing the number of variables in the model (results not
shown) did not improve its prediction of the outcome, and
sensitivity decreased further, making the prediction rule
worthless in selecting anyone for management without urgent
endoscopy.
The specificity for the predictor model of 98% and 95% CI of
95 - 100% meet our predetermined requirement that a
predictive tool should not have specificity of less than 95%.
Of the 200 patients in the study, 30 (15%) satisfied the
prediction rule (haemoglobin greater than 10 g/dl, no melaena
and no syncope). These patients would have been sent home
without undergoing urgent endoscopy. However, 3 had been
misclassified as they had a poor outcome. These 3 patients,
who were false-positives according to the test criteria, required
sclerotherapy to control haemorrhage. They did not have blood
transfusion or surgery and were alive at 1 month. The clinical
implications of these findings are that the test would result in a
moderate impact on the reduction of unnecessary endoscopies
(15% of admissions) with 5% or less of the patients with poor
outcome being sent home without urgent endoscopy.
The prediction rule could be easily applied even in poorly
resourced health centres, as it does not involve sophisticated
equipment. It should be noted that these criteria help identify
those who will get better anyway, regardless of endoscopy. It
does not necessarily identify those who do not require
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endoscopy for diagnostic purposes.
However, a clinical decision rule is ‘data driven’ in that it is
derived from a specific sample of patients. The test may not
perform as well in different populations and therefore needs to
be validated.15 Patients included in the study are not
representative of our general population. Patients presenting to
private hospitals with UGIB may be different at presentation
from the study population in that they may present earlier or
might have different degrees of exposure to risk factors for
UGIB. Their outcome may differ due to different management
strategies such as transfusion practices. For this reason, a
validation study is required before the decision rule is
considered for application in clinical practice.
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